GABY Inc.
GABLFOTCHealthcare
$0.00
+$0.00(+45.00%)
Market Cap$2657328
P/E Ratio—
52W High$0.00145
52W Low$0.00145
GABY Inc. (GABLF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GABLF · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2023Report Date: May 30, 2023EPS Actual
-$0.00
Revenue
$0.00B
Est. $0.01B · -37.7%
Fiscal Period
Q2 FY2023
FY ends December
Report Date
May 30, 2023
After Market Close
▼ Miss Revenue
GABLF reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $6.21B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$6.21B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2024 | Jun 14, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | Apr 29, 2024 | — | — | — | — | — | — |
| ◌ Q4 FY2023 | Nov 30, 2023 | — | — | — | — | — | — |
| ◌ Q3 FY2023 | Aug 29, 2023 | — | — | — | — | — | — |
| — Q2 FY2023 | May 30, 2023 | — | -$0.00 | — | $0.00B | $0.01B | -37.7% |
| — Q2 FY2023 | May 1, 2023 | — | -$0.02 | — | $0.00B | $0.01B | -25.7% |
| — Q4 FY2022 | Nov 30, 2022 | — | -$0.01 | — | $0.00B | $0.00B | -20.3% |
| — Q3 FY2022 | Aug 29, 2022 | — | -$0.00 | — | $0.00B | $0.01B | -46.4% |
Q2 FY2024
Jun 14, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Apr 29, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 30, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Aug 29, 2023
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
May 30, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2023
May 1, 2023
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2022
Nov 30, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2022
Aug 29, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2023 | May 30, 2023 | — | $0.00 | $0.00 | +0.00% |
| — Q2 FY2023 | May 1, 2023 | — | $0.00 | $0.00 | +0.00% |
| — Q4 FY2022 | Nov 30, 2022 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2022 | Aug 29, 2022 | — | $0.01 | $0.01 | +1.32% |
| — Q2 FY2022 | May 30, 2022 | — | $0.02 | $0.02 | +1.96% |
| — Q2 FY2022 | May 2, 2022 | — | $0.02 | $0.02 | +0.00% |
| — Q4 FY2021 | Nov 24, 2021 | — | $0.02 | $0.02 | +5.11% |
| — Q3 FY2021 | Aug 31, 2021 | — | $0.04 | $0.04 | +18.46% |
Q2 FY2023+0.00%
Report Date
May 30, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q2 FY2023+0.00%
Report Date
May 1, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2022+0.00%
Report Date
Nov 30, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2022+1.32%
Report Date
Aug 29, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2022+1.96%
Report Date
May 30, 2022
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q2 FY2022+0.00%
Report Date
May 2, 2022
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q4 FY2021+5.11%
Report Date
Nov 24, 2021
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q3 FY2021+18.46%
Report Date
Aug 31, 2021
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.04
Beat Rate0 / 8 quarters
Largest Move+18.46% (Q3 FY2021)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GABLF ends December
GABY Inc. (GABLF) most recently reported earnings on May 30, 2023 for Q2 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —). The next GABLF earnings date is expected around September 1, 2026.
Each quarter, investors track GABLF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GABLF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GABLF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GABLF earnings · 4 questionsGABY Inc.'s next earnings report is expected around September 1, 2026. GABLF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GABLF historically reports after market close (AMC).
GABLF earnings datewhen is GABLF earningsGABLF next earnings datewhen does GABLF report earningsGABLF earnings calendar
▸ Source: FMP · GABY Inc. SEC filings · US GAAP · GABY Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026